These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Expression of telomerase and p53 in ameloblastoma]. Zhong M; Zhang LH; Wang J; Zhang B; Hou L Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):127-31. PubMed ID: 14661519 [TBL] [Abstract][Full Text] [Related]
44. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872 [TBL] [Abstract][Full Text] [Related]
45. [A clinical study concerning survival of operative cases for the transitional cell carcinoma of the upper urinary tract]. Yumura Y; Fujikawa A; Tajiri T; Kawai M; Yokomizo Y; Moriyama M; Noguchi S; Ogo Y; Kobayashi K; Senga Y; Fujinami K; Yamashita Y; Okajima K Hinyokika Kiyo; 2009 Feb; 55(2):65-70. PubMed ID: 19301609 [TBL] [Abstract][Full Text] [Related]
46. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706 [TBL] [Abstract][Full Text] [Related]
47. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. Novara G; De Marco V; Dalpiaz O; Gottardo F; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V BJU Int; 2008 Jun; 101(11):1368-74. PubMed ID: 18241252 [TBL] [Abstract][Full Text] [Related]
48. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Soder AI; Going JJ; Kaye SB; Keith WN Oncogene; 1998 Feb; 16(8):979-83. PubMed ID: 9519871 [TBL] [Abstract][Full Text] [Related]
49. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract. Nakanishi K; Tominaga S; Kawai T; Torikata C; Aurues T; Ikeda T Virchows Arch; 1998 May; 432(5):445-50. PubMed ID: 9645444 [TBL] [Abstract][Full Text] [Related]
50. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631 [TBL] [Abstract][Full Text] [Related]
51. Glucose-regulated protein 78 expression in urothelial carcinoma of the upper urinary tract. Uematsu K; Ogata S; Nakanishi K; Hiroi S; Tominaga S; Aida S; Kawai T BJU Int; 2010 Sep; 106(6):873-8. PubMed ID: 20039870 [TBL] [Abstract][Full Text] [Related]
52. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607 [TBL] [Abstract][Full Text] [Related]
53. Expressions of human telomerase mRNA component (hTERC) and telomerase reverse transcriptase (hTERT) mRNA in effusion cytology. Hiroi S; Nakanishi K; Kawai T Diagn Cytopathol; 2003 Oct; 29(4):212-6. PubMed ID: 14506674 [TBL] [Abstract][Full Text] [Related]
54. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460 [TBL] [Abstract][Full Text] [Related]
55. In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion. Ozaki S; Harada K; Sanzen T; Watanabe K; Tsui W; Nakanuma Y Hepatology; 1999 Oct; 30(4):914-9. PubMed ID: 10498642 [TBL] [Abstract][Full Text] [Related]
56. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359 [TBL] [Abstract][Full Text] [Related]
57. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related]
58. Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract. Nakanishi K; Ogata S; Hiroi S; Tominaga S; Aida S; Kawai T Am J Clin Pathol; 2008 Jul; 130(1):43-9. PubMed ID: 18550469 [TBL] [Abstract][Full Text] [Related]
59. p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder. Fleshner N; Kapusta L; Ezer D; Herschorn S; Klotz L J Urol; 2000 Oct; 164(4):1177-82. PubMed ID: 10992361 [TBL] [Abstract][Full Text] [Related]
60. Telomerase expression in sebaceous carcinoma of the eyelid. Li B; Li ND; Xu XL; Zheng BH; Sun XL; Li LQ; Chen CX Chin Med J (Engl); 2004 Mar; 117(3):445-8. PubMed ID: 15043789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]